Αρχειοθήκη ιστολογίου

Σάββατο 9 Σεπτεμβρίου 2017

PACIFIC trial of durvalumab for stage III NSCLC

Dr Paz-Ares speaks with ecancer at ESMO 2017 about the outcomes of patients with unresectable advanced lung cancer treated with anti-PD-L1 durvalumab, following chemoradiation. He reports improved progression free survival compared to placebo, noting...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2gS42ZY
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader